cupure logo
trumpzelenskywarukrainewhitehousechinaandrewprincetomahawk

AstraZeneca plans New York Stock Exchange listing but isn’t quitting London

FTSE 100’s second-biggest firm will also retain HQ in Cambridge and maintain its London listingBusiness live – latest updatesThe UK’s biggest drugmaker AstraZeneca said it will directly list its shares on the New York Stock Exchange, putting them on an equal footing to its London listing, to attract more investors, but affirmed its headquarters will stay in the UK.The FTSE 100 company said its direct listing in New York will replace trading in its “American depositary receipts” (ADRs) – which give US investors exposure to a non-US company – on the Nasdaq. Continue reading...

Comments

World news